CN1132096A - Chinese drug for treatment of hemiplegia - Google Patents

Chinese drug for treatment of hemiplegia Download PDF

Info

Publication number
CN1132096A
CN1132096A CN 95117933 CN95117933A CN1132096A CN 1132096 A CN1132096 A CN 1132096A CN 95117933 CN95117933 CN 95117933 CN 95117933 A CN95117933 A CN 95117933A CN 1132096 A CN1132096 A CN 1132096A
Authority
CN
China
Prior art keywords
radix
rhizoma
hemiplegia
medicine
chinese patent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 95117933
Other languages
Chinese (zh)
Other versions
CN1055220C (en
Inventor
侯忠义
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95117933A priority Critical patent/CN1055220C/en
Publication of CN1132096A publication Critical patent/CN1132096A/en
Application granted granted Critical
Publication of CN1055220C publication Critical patent/CN1055220C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese patent medicine in the form of oral liquid for curing hemiplegia with 95% effective rate and less toxic by-effect is prepared from 20 Chinese-medicinal components such as astragalus root, uncaria stem with hooks, scorpion, rehmannia root, red peony root, musk, etc.

Description

The Chinese patent medicine " compound recipe hemiplegia recovery ball " of treatment hemiplegia
The invention belongs to a kind of oral Chinese patent medicine for the treatment of the hemiplegia disease.
Hemiplegia is the sequela that cerebral thrombosis, cerebral hemorrhage, cerebral embolism etc. cause, this sick Therapeutic Method is different, middle in recent years medical circles are in conjunction with the experience of doctor family treatment hemiplegia in the present age, sum up acute stage to take stopgap measures, sequela stage is then based on the method for the treatment of both the principal and secondary aspects of a disease, the Therapeutic Principle adopts eliminating phlegm by purgation in the bowels, suppressing the hyperactive liver and subsiding YANG and promoting blood circulation to remove obstruction in the collateral, supplementing QI and nourishing YIN etc. respectively, and state's internal therapy primary disease effective percentage is about about 90% at present.
The present invention aims to provide the oral Chinese patent medicine compound recipe hemiplegia recovery ball of a kind of curative effect height, low price, treatment hemiplegia that toxic and side effects is little.
For achieving the above object, the raw material of Chinese medicine weight proportion following (wherein b is Unit Weight part) that the present invention adopts,
Radix Astragali 100-140b Ramulus Uncariae Cum Uncis 35-55b Scorpio 8-10b
Scolopendra 8-10b Radix Rehmanniae 24-30b Radix Paeoniae Rubra 16-20b
Radix Salviae Miltiorrhizae 65-85b Flos Carthami 24-30b Pheretima 27-33b
Flos Chrysanthemi 24-30b Rhizoma Gastrodiae 2-4b Poria 35-55b
Rhizoma Atractylodis Macrocephalae 16-20b Ramulus Mori 35-55b Radix Glycyrrhizae 16-20b
Fructus Corni 16-20b Rhizoma Dioscoreae 35-55b Cortex Moutan 16-20b
The orange 35-55b of Radix Scutellariae 7-11b
Moschus 0.0002-0.0004b
The raw material of Chinese medicine of said ratio is made oral administration pills.
Hemiplegia mainly is because of disorder of emotion or eating and drinking without temperance or prolonged illness overwork, cause the body imbalance between YIN and YANG, internal organs, meridians, QI and blood dysfunction, thus cause excessive rising of liver-YANG, attacking up head and eyes, or phlegm stagnating in meridian makes brain disturb wind, or the hepatic and renal YIN deficiency, brains wind are disturbed due to the head.
At above-mentioned Chinese medical discrimination, we reuse Radix Astragali QI invigorating, join Radix Paeoniae Rubra, Flos Carthami, the Radix Salviae Miltiorrhizae promoting the circulation of blood dissipating blood stasis of invigorating blood circulation, Scorpio, Scolopendra, the Pheretima dredge the meridian passage that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., Ramulus Uncariae Cum Uncis, Flos Chrysanthemi, Rhizoma Gastrodiae suppressing the hyperactive liver and subsiding YANG dispel the wind, the Rhizoma Atractylodis Macrocephalae, Poria, Ramulus Mori spleen invigorating eliminating dampness and dredging channels, Fructus Corni, Rhizoma Dioscoreae, Cortex Moutan nourishing the kidney and liver yin fluid astringing, Radix Scutellariae, orange heat clearing and damp drying are reduced phlegm, and the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is a messenger drug, help again with the sharp key refreshment of a little Moschus switch, and help other medicines performance effect.
We mix to add and subtract for sides such as BUYANG HUANWU TANG, phlegm-removing decoction, TIANMA GOUTENG YIN, LIUWEI DIHUANG TANG and form, and full side's compatibility has inrigorating qi and promoting blood circulation, the dissipating blood stasis that stimulates the menstrual flow, suppressing the hyperactive liver to relieve the wind syndrome, heat clearing away eliminate the phlegm, the effect of nourishing the kidney and liver, the refreshment of having one's ideas straightened out.
Take this medicine and can improve the blood vessel circulation, strengthen blood flow, reduce cerebral vascular resistance, anti-platelet aggregation cures mainly hemiplegia and sequela due to the cerebrovascular disease such as paralysis due to windstroke, hemiplegia, facial hemiparalysis, aphasia, aphasia or slurred speech, blurred vision, numb limbs and tense tendons, walking hardship, bones and muscles pain, contracture of the limbs.
According to 100 routine clinical treatment observations:
Male's 79 examples, women's 21 examples, maximum 76 years old, minimum 46 years old, average year made 61 years old.
The case choice criteria
1, primary symptom: hemiplegia, crooked mouth and tongue, the mind unconsciousness, stiff tongue or in silence, partially
The body numbness;
2, Acute onset;
3, sick sending out has inducement more, and premonitory symptom is arranged before not sending out more;
4, good sending out makes more than 40 years old in year;
Chinese medical discrimination
1, in through the knot: wind-phlegm class, deficiency of YIN liver-yang hyperactivity class
2, middle internal organs: close the disease class, take off the disease class, the sequela class
Curative effect is declared criterion
1, be almost recovered: conscious, language performance is normal, upper limb shoulder joint articulations digitorum manus
Movable normal, the lower limb toe joint is stretched and is bent freely, and life can be taken care of oneself.
2, produce effects: mind is gradually clear-headed, and language performance is general, upper limb shoulder joint, articulations digitorum manus
Can go up act and move respectively, but muscular strength is poor, lower limb can be raised more than 45 °, toe joint
Can stretch in the wrong, but a little less than the power.
3, effective: drowsy, after waking up can and people's words, speak that it is incomplete to express, last act less than
Shoulder can be clenched fist and be stretched finger, and lower limb can be balanced, and toe joint is slightly moving.
4, invalid: cardinal symptom does not have change.
Test method
1, compound recipe hemiplegia recovery ball is oral, every day secondary, each half ball.
2, inactive without exception other Chinese and western drugses of duration of test.
3, three months is a course of treatment.
Observed result
The sick kind The example number Be almost recovered Produce effects ?% Effectively ?% Invalid ??% Total effective rate
Cerebral thrombosis 66 ?20 ?31.8 ?20 31.8 ?24 36.3 ?2 ?1 ?99%
Cerebral hemorrhage 27 ??8 ?29.6 ??4 14.8 ?13 48 ?2 ?7.4 ?93.6%
Cerebral embolism 7 ??2 ?28.5 ??2 28.5 ?2 28.5 ?1 ?14.2 ?85.8%
Discuss
1, this strain pure Chinese medicinal preparation is used for 100 routine patients, except that 5 examples are invalid, does not have any untoward reaction.
2, all react general 1-2 and can recover the course of treatment through following up a case by regular visits to patient and patient letter, determined curative effect, taking convenience is a kind of Chinese medicine preparation that is worthy to be popularized.
3, this medicine clinical practice, limbs have in various degree heating, pain, formication mostly in a short time, are that this symptom can be recovered without treatment due to the drug effect.
Can find out that according to above-mentioned material the clinical effective rate of this Chinese patent medicine can reach 95%, be higher than the mean level of present treatment primary disease, and toxic and side effects is little, determined curative effect, low price, taking convenience.
The raw material of Chinese medicine weight proportion following (b is Unit Weight part) that 1 example of embodiment adopts
Radix Astragali 140b Ramulus Uncariae Cum Uncis 55b Scorpio 10b
Scolopendra 10b Radix Rehmanniae 30b Radix Paeoniae Rubra 20b
Radix Salviae Miltiorrhizae 85b Flos Carthami 30b Pheretima 33b
Flos Chrysanthemi 30b Rhizoma Gastrodiae 4b Poria 55b
Rhizoma Atractylodis Macrocephalae 20b Ramulus Mori 55b Radix Glycyrrhizae 20b
Fructus Corni 20b Rhizoma Dioscoreae 55b Cortex Moutan 20b
This routine manufacture method of the orange 55b Moschus of Radix Scutellariae 11b 0.0004b is as follows: 1, get the Chinese herbal medicine of respectively distinguishing the flavor of by above-mentioned weight proportion; 2, be ground into fine powder, sieve, mixing; 3, every 100g powder adds 80-110g Mel, stirs, and one-tenth sticks together, and shaping is made the 9g big honeyed pills.Usage and consumption: oral, every day secondary, each half ball, warm yellow wine send down, and is each
Join yellow wine 10ml treatment time: taboo in three months and attention: period in a medicine is avoided tobacco and wine and oils and fats food, prevents direct stimulation, mistake
Degree is sad, fierceness and strenuous exercise.The raw material of Chinese medicine weight proportion following (b is Unit Weight part) that embodiment 2, this example adopt
Radix Astragali 100b Ramulus Uncariae Cum Uncis 35b Scorpio 8b
Scolopendra 8b Radix Rehmanniae 24b Radix Paeoniae Rubra 16b
Radix Salviae Miltiorrhizae 65b Flos Carthami 24b Pheretima 27b
Flos Chrysanthemi 24b Rhizoma Gastrodiae 2b Poria 35b
Rhizoma Atractylodis Macrocephalae 16b Ramulus Mori 35b Radix Glycyrrhizae 16b
Fructus Corni 16b Rhizoma Dioscoreae 35b Cortex Moutan 16b
The orange 35b Moschus of Radix Scutellariae 11b 0.0002b makes honeyed pill with above-mentioned raw material of Chinese medicine with conventional method.
The raw material of Chinese medicine weight proportion following (b is Unit Weight part) that embodiment 3, this example adopt
Radix Astragali 120b Ramulus Uncariae Cum Uncis 45b Scorpio 9b Scolopendra 9b
Radix Rehmanniae 27b Radix Paeoniae Rubra 18b Radix Salviae Miltiorrhizae 75b Flos Carthami 27b
Pheretima 30b Flos Chrysanthemi 27b Rhizoma Gastrodiae 3b Poria 45b
Rhizoma Atractylodis Macrocephalae 18b Ramulus Mori 45b Radix Glycyrrhizae 18b Fructus Corni 18b
The orange 45b of Rhizoma Dioscoreae 45b Cortex Moutan 18b Radix Scutellariae 9b
Moschus 0.0003b Concha Haliotidis 60b Radix Gentianae 9b Radix Angelicae Sinensis 30b
Bungarus Parvus 1b Spica Prunellae 27b
Rhizoma pinelliae cordatae 36b Rhizoma Arisaematis 27b Fructus Aurantii Immaturus 27b Caulis Bambusae In Taenia 45b
Radix Puerariae 36b Radix Aristolochiae Fangchi 27b Rhizoma Typhonii 27b Fructus Lycii 18b
Radix Rehmanniae Preparata 27b Rhizoma Alismatis 18b
This example adds the Radix Angelicae Sinensis promoting the circulation of blood dissipating blood stasis of invigorating blood circulation again on the main formula basis, the Bungarus Parvus dredge the meridian passage that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., Concha Haliotidis, Spica Prunellae, Rhizoma Typhonii suppressing the hyperactive liver and subsiding YANG dispel the wind, Radix Stephaniae Tetrandrae spleen invigorating eliminating dampness and dredging channels, Fructus Lycii, Radix Rehmanniae Preparata, Rhizoma Alismatis nourishing the kidney and liver yin fluid astringing, Radix Gentianae, Caulis Bambusae In Taenia, Radix Puerariae, Rhizoma pinelliae cordatae, Rhizoma Arisaematis, Fructus Aurantii Immaturus heat clearing and damp drying are reduced phlegm.
The raw material of Chinese medicine of said ratio is made honeyed pill by embodiment 1 described method.

Claims (2)

1, the Chinese patent medicine compound recipe hemiplegia recovery ball of treatment hemiplegia is characterized in that, it is (b is Unit Weight part) that this Chinese patent medicine adopts the weight proportion of raw material of Chinese medicine
Radix Astragali 100-140b Ramulus Uncariae Cum Uncis 35-55b Scorpio 8-10b
Scolopendra 8-10b Radix Rehmanniae 24-30b Radix Paeoniae Rubra 16-20b
Radix Salviae Miltiorrhizae 65-85b Flos Carthami 24-30b Pheretima 27-33b
Flos Chrysanthemi 24-30b Rhizoma Gastrodiae 2-4b Poria 35-55b
Rhizoma Atractylodis Macrocephalae 16-20b Ramulus Mori 35-55b Radix Glycyrrhizae 16-20b
Fructus Corni 16-20b Rhizoma Dioscoreae 35-55b Cortex Moutan 16-20b
The orange 35-55b of Radix Scutellariae 7-11b
Moschus 0.0002-0.0004b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral administration pills.
2, the Chinese patent medicine compound recipe hemiplegia recovery ball of treatment hemiplegia according to claim 1 is characterized in that, it is (b is unit weight part) that this medicine adopts the weight proportion of raw material of Chinese medicine
Radix Astragali 120b Ramulus Uncariae Cum Uncis 45b Scorpio 9b Scolopendra 9b
Radix Rehmanniae 27b Radix Paeoniae Rubra 18b Radix Salviae Miltiorrhizae 75b Flos Carthami 27b
Pheretima 30b Flos Chrysanthemi 27b Rhizoma Gastrodiae 3b Poria 45b
Rhizoma Atractylodis Macrocephalae 18b Ramulus Mori 45b Radix Glycyrrhizae 18b Fructus Corni 18b
The orange 45b of Rhizoma Dioscoreae 45b Cortex Moutan 18b Radix Scutellariae 9b
Moschus 0.0003b Concha Haliotidis 60b Radix Gentianae 9b Radix Angelicae Sinensis 30b
Bungarus Parvus 1b Spica Prunellae 27b
Rhizoma pinelliae cordatae 36b Rhizoma Arisaematis 27b Fructus Aurantii Immaturus 27b Caulis Bambusae In Taenia 45b
Radix Puerariae 36b Radix Aristolochiae Fangchi 27b Rhizoma Typhonii 27b Fructus Lycii 18b
Radix Rehmanniae Preparata 27b Rhizoma Alismatis 18b
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of honeyed pill dosage form.
CN95117933A 1995-11-02 1995-11-02 Chinese drug for treatment of hemiplegia Expired - Fee Related CN1055220C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95117933A CN1055220C (en) 1995-11-02 1995-11-02 Chinese drug for treatment of hemiplegia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95117933A CN1055220C (en) 1995-11-02 1995-11-02 Chinese drug for treatment of hemiplegia

Publications (2)

Publication Number Publication Date
CN1132096A true CN1132096A (en) 1996-10-02
CN1055220C CN1055220C (en) 2000-08-09

Family

ID=5081466

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95117933A Expired - Fee Related CN1055220C (en) 1995-11-02 1995-11-02 Chinese drug for treatment of hemiplegia

Country Status (1)

Country Link
CN (1) CN1055220C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1072497C (en) * 1998-06-07 2001-10-10 黄海峰 Medicine for treating hemiplegia and preparation method thereof
CN104225275A (en) * 2014-09-09 2014-12-24 青岛市市立医院 Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of composition
CN104740363A (en) * 2015-03-20 2015-07-01 鄢明亮 Traditional Chinese medicine preparation for treating apoplectic hemiplegia and preparation method
CN105288225A (en) * 2014-07-13 2016-02-03 胡培芹 Chinese patent medicines for treating cerebral palsy
CN114504635A (en) * 2022-04-08 2022-05-17 邓山松 Chinese patent medicine for treating apoplexy sequela

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074374A (en) * 1992-11-28 1993-07-21 吕汇川 Hemiplegia recovery oral liquid and compound method
CN1092666A (en) * 1993-03-19 1994-09-28 杨诗琴 A kind of hypotensive palsy-treating preparation and preparation method thereof
CN1104910A (en) * 1994-06-09 1995-07-12 李全海 Medicinal liquor for hemiparalysis
CN1106674A (en) * 1994-10-13 1995-08-16 汪志伟 Traditional Chinese medicine for curing paralysis

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1072497C (en) * 1998-06-07 2001-10-10 黄海峰 Medicine for treating hemiplegia and preparation method thereof
CN105288225A (en) * 2014-07-13 2016-02-03 胡培芹 Chinese patent medicines for treating cerebral palsy
CN104225275A (en) * 2014-09-09 2014-12-24 青岛市市立医院 Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of composition
CN104740363A (en) * 2015-03-20 2015-07-01 鄢明亮 Traditional Chinese medicine preparation for treating apoplectic hemiplegia and preparation method
CN114504635A (en) * 2022-04-08 2022-05-17 邓山松 Chinese patent medicine for treating apoplexy sequela
CN114504635B (en) * 2022-04-08 2023-03-14 邓山松 Chinese patent medicine for treating apoplexy sequela

Also Published As

Publication number Publication date
CN1055220C (en) 2000-08-09

Similar Documents

Publication Publication Date Title
CN1169541C (en) Medicine for treating rheumatoid arthritis
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN1857541A (en) Plaster for treating rheumatism and osteoarthrosis
CN1485083A (en) Capsule for thyroid cancer / tumor and lymph node
CN1861187A (en) Medicated wine for treating rheumatosis and osteoarthropathy
CN1286518C (en) Chinese medicinal prescription for treating gastropathy
CN1814208A (en) Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis
CN1390585A (en) Chinese medicine for detoxication purpose and its preparing process
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN1218721C (en) Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease
CN102335336A (en) Traditional Chinese medicine for treating lupus sebaceus
CN1055220C (en) Chinese drug for treatment of hemiplegia
CN1237443A (en) Medicine for curing rheumatic heart disease
CN105213766B (en) A kind of dredging collateral supports knee soup and preparation method thereof
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN1285354C (en) Medicine for treating cerebral infarction
CN1310014A (en) Lumbago treating Chinese medicine
CN1308025C (en) Medicine for treating paraplegia and its preparing method
CN1086586C (en) Medicine for treating cardiac and cerebral vascular diseases and its preparation
CN1200724C (en) Pill for activating collateral flow and removing spur
CN104147570A (en) Traditional Chinese medicine preparation for treating children with iron deficiency anemia
CN1186074C (en) Chinese medicinal proprietary for treating hemiplegic by apoplexia-Fuzhengpiantanwan
CN1515284A (en) Rongshuan jiannaokang thrombolytic
CN1342478A (en) Medical wine for treating rheumatism
CN1241602C (en) Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1032833

Country of ref document: HK

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee